Announced Wed, 1 Jul · 19:25 IST
Board Meeting Rescheduled to 2nd July 2026 to Approve FY26 Audited Results
Board & Shareholder Meetings View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-7.7%1-day move
₹6.50
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-7.7-7.7-11.8-13.5-3.1-11.5-20.0———
Up moveDown movePending
AI summary
Dipna Pharmachem's board met on 1st July 2026 and rescheduled a follow-up meeting to 2nd July 2026 at 4:00 PM at the Ahmedabad registered office. The rescheduled meeting will consider and approve the Audited Financial Results for the half year and full year ended 31st March 2026, along with the Auditor's Report, and any other matter with the Chairperson's permission.
Likely market impact
FY26 audited earnings likely to be announced on 2nd July 2026. Watch for results and any board decisions that could move the stock.